Insider · CIK 0001709976

Gallagher Brian M. Jr.

Reports to the SEC for 3 companies · CONSHOHOCKEN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001709976

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-13	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+800 sh	—	—	800
2024-02-19	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2023-06-22	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-01-20	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+50.9K sh	—	—	50,938
2022-06-23	eFFECTOR Therapeutics, Inc.P Purchase	Director	PPurchase	+30K sh	$1.59	+$47.7K	30,000
2022-06-09	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-10-06	eFFECTOR Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-10-06	eFFECTOR Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-08-25	eFFECTOR Therapeutics, Inc.A Award	Director	AAward	+4.82M sh	—	—	4,822,114
2021-08-25	eFFECTOR Therapeutics, Inc.Earn-out RightA Award	Director	AAward	+605K sh	—	—	605,338
2018-07-02	Translate Bio, Inc.C Conversion	Director	CConversion	+1.67M sh	—	—	1,674,016
2018-07-02	Translate Bio, Inc.C Conversion	Director	CConversion	+1.3M sh	—	—	2,974,132
2018-07-02	Translate Bio, Inc.C Conversion	Director	CConversion	+455K sh	—	—	3,428,682
2018-07-02	Translate Bio, Inc.P Purchase	Director	PPurchase	+269K sh	$13.00	+$3.5M	3,697,912
2018-07-02	Translate Bio, Inc.Series A Preferred StockC Conversion	Director	CConversion	−9.3M sh	—	—	0
2018-07-02	Translate Bio, Inc.Series B Preferred StockC Conversion	Director	CConversion	−7.22M sh	—	—	0
2018-07-02	Translate Bio, Inc.Series C Preferred StockC Conversion	Director	CConversion	−2.53M sh	—	—	0
2017-07-25	RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-07-05	RNTXRein Therapeutics, Inc.C Conversion	Director	CConversion	+1.16M sh	—	—	1,158,186
2017-07-05	RNTXRein Therapeutics, Inc.P Purchase	Director	PPurchase	+273K sh	$15.00	+$4.1M	1,431,519
2017-07-05	RNTXRein Therapeutics, Inc. · Series D Preferred StockC Conversion	Director	CConversion	−6.78M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series E-2 Preferred StockC Conversion	Director	CConversion	−1.47M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series E-3 Preferred StockC Conversion	Director	CConversion	−1.28M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series F Preferred StockC Conversion	Director	CConversion	−1.98M sh	—	—	0

Recent filings

Accepted (ET)
Jun 134
Gallagher Brian M. Jr.0000950170-24-073199
SEC(opens sec.gov)
Feb 214
Gallagher Brian M. Jr.0001209191-24-003688
SEC(opens sec.gov)
Jun 224
Gallagher Brian M. Jr.0001209191-23-039195
SEC(opens sec.gov)
Jan 244
Gallagher Brian M. Jr.0001209191-23-004596
SEC(opens sec.gov)
Jun 274
Gallagher Brian M. Jr.0001209191-22-039356
SEC(opens sec.gov)
Jun 134
Gallagher Brian M. Jr.0001209191-22-036445
SEC(opens sec.gov)
Dec 174/A
Gallagher Brian M. Jr.0000905718-21-001619
SEC(opens sec.gov)
Oct 84
Gallagher Brian M. Jr.0001209191-21-060061
SEC(opens sec.gov)
Aug 274
Gallagher Brian M. Jr.0001209191-21-053717
SEC(opens sec.gov)
Jul 54
Gallagher Brian M. Jr.0000899243-18-019455
SEC(opens sec.gov)
Jul 274
Gallagher Brian M. Jr.0000899243-17-019209
SEC(opens sec.gov)
Jul 64
AILERON THERAPEUTICS INC0000899243-17-018014
SEC(opens sec.gov)

Companies

Address

C/O S.R. ONE, LIMITED 161 WASHINTON STREET, SUITE 500

CONSHOHOCKEN, PA, 19428